---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-022271"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:22:28.731483+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aquestive appoints new CMO and adds independent director to Board

## Summary
- Appointed Kenneth Truitt, M.D. as Chief Medical Officer effective Sept 6, 2022.
- Dr. Truitt granted inducement option for 100,000 shares; vesting 25%/25%/50% over 3 years.
- Appointed Timothy E. Morris to Board (Class I) effective Aug 5, 2022, filling newly created seat.
- Mr. Morris receives 28,500 stock options vesting 1/3 annually; will serve on Audit Committee.
- Board Chair Santo Costa steps down from Audit Committee; Board size increased to seven.

## SEC filing metadata
- accession: 0001628280-22-022271
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828022022271/0001628280-22-022271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828022022271/aqst-20220810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-022271
- JSON: https://secwatch.observer/filing/0001628280-22-022271.json
- Plain text: https://secwatch.observer/filing/0001628280-22-022271.txt

## Key facts
- Executive change
  Timothy E. Morris was appointed as Director at Aquestive Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 10, 2022, the Company announced the appointment of Timothy E. Morris to the Company’s Board, effective August 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828022022271/0001628280-22-022271-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.